Metraipolis › archive › dc_5ab74ec34808

Reduced ocular perfusion after intravitreal Aflibercept and faricimab: an exploratory study for Tie2 receptor distribution in ophthalmic capillaries — Europe PMC PMID:41081892

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41081892
DOI
10.1007/s00417-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-09T09:32:03.930Z
SHA-256 of the archived text
dc9687570ebf2dd71d64690e41e1a7b3cd801edf126599604d4c4f0eb0dafd0c
Stable URL of this page
https://metraipolis.com/documento/dc_5ab74ec34808

How to cite

Reduced ocular perfusion after intravitreal Aflibercept and faricimab: an exploratory study for Tie2 receptor distribution in ophthalmic capillaries — Europe PMC PMID:41081892 — Europe PMC (en), https://europepmc.org/article/MED/41081892 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ab74ec34808 (Metraipolis archive dc_5ab74ec34808, sha256 dc9687570ebf2dd71d64690e41e1a7b3cd801edf126599604d4c4f0eb0dafd0c)
BibTeX
@misc{dc5ab74ec34808,
  title = {Reduced ocular perfusion after intravitreal Aflibercept and faricimab: an exploratory study for Tie2 receptor distribution in ophthalmic capillaries — Europe PMC PMID:41081892},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41081892},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ab74ec34808; sha256 dc9687570ebf2dd71d64690e41e1a7b3cd801edf126599604d4c4f0eb0dafd0c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41081892. Agents can read the archived copy with the MCP tool read_document.